Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline - a PET Study in Healthy Human Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01794975

Organisation Name: University of Turku

Overal Status: Completed

Start Date: August 2012

Last Update: February 20, 2013

Lead Sponsor: University of Turku

Brief Summary: The primary objective of the study is to further investigate whether striatal [11C]ORM-13070 uptake can be reduced by physiological and pharmacological challenges that increase the synaptic concentrations of noradrenaline in the human brain. Each subject will undergo 3 PET scans, a baseline PET scan and two scans with noradrenaline challenges: intravenous administration of ketamine and oral administration of atomoxetine combined with a cold pressor test where the subject's foot is placed in an 8 °C water basin. Eight healthy male subjects will be included in the study.

Conditions:
  • Changes in Striatal [11C]ORM-13070 Binding.


Total execution time in seconds: 0.20375490188599